STAAR lenses granted NTIOL status
The Afinity Collamer aspheric single piece Intraocular Lens (IOL) Model CC4204A and the Elastimide Silicone aspheric IOL Model AQ2015A, both manufactured and marketed by STAAR Surgical, have been designated New Technology IOLs (NTIOLs) by the US Centers for Medicare and Medicaid.
The Afinity Collamer aspheric single piece Intraocular Lens (IOL) Model CC4204A and the Elastimide Silicone aspheric IOL Model AQ2015A, both manufactured and marketed by STAAR Surgical, have been designated New Technology IOLs (NTIOLs) by the US Centers for Medicare and Medicaid. STAAR also already has NTIOL status for the Collamer aspheric three-piece IOL.
NTIOL status, granted if an IOL is able to demonstrate that it provides new clinical benefits, enhances access to the latest IOL technologies to beneficiaries of the Medicare/Medicaid programmes in the US by conferring an additional reimbursement of $50 for each NTIOL provided to these beneficiaries in an Ambulatory Surgical Center (ASC).
The Afinity Collamer single piece lens, which can be implanted through a 2.2 mm incision with the nanoPOINT Injector System (STAAR Surgical), and the Elastimide Silicone lens belong to the Reduced Spherical Aberrations subset of NTIOLs. The additional reimbursement for which these lenses are now eligible will run until 26 February 2011.
